Literature DB >> 17168568

G-protein-coupled receptor trafficking: understanding the chemical basis of health and disease.

Alfredo Ulloa-Aguirre1, Jo Ann Janovick, Alfredo Leaños Miranda, P Michael Conn.   

Abstract

The primary function of cell surface receptors is to recognize specific chemical signals from other substances and produce a biological response. Point mutations in cell surface receptors may result in production of misfolded proteins that are translated but do not reach their proper functional destination in the cell. Also, for some G-protein-coupled receptors, large amounts of wild-type receptor may be destroyed without arriving at the plasma membrane (PM). For the human gonadotropin-releasing hormone receptor, this "inefficiency" has resulted from strong and convergent evolutionary pressure, producing receptor molecules that are sensitive to single changes in chemical charge and are delicately balanced between expression at the PM or retention/degradation in the endoplasmic reticulum. This Perspective focuses on the evolved mechanisms that control PM expression of this receptor at this post-translational level.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17168568     DOI: 10.1021/cb600360h

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  22 in total

1.  Adenosine A2A receptor is involved in cell surface expression of A2B receptor.

Authors:  Kengo Moriyama; Michail V Sitkovsky
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

Review 2.  Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.

Authors:  Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2011-01

3.  Biochemical mechanism of pathogenesis of human gonadotropin-releasing hormone receptor mutants Thr104Ile and Tyr108Cys associated with familial hypogonadotropic hypogonadism.

Authors:  Guadalupe Maya-Núñez; Jo Ann Janovick; Arturo Aguilar-Rojas; Eduardo Jardón-Valadez; Alfredo Leaños-Miranda; Teresa Zariñan; Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2011-01-26       Impact factor: 4.102

Review 4.  Trafficking and quality control of the gonadotropin releasing hormone receptor in health and disease.

Authors:  P Michael Conn; Jo Ann Janovick
Journal:  Mol Cell Endocrinol       Date:  2008-11-18       Impact factor: 4.102

Review 5.  Assay strategies for identification of therapeutic leads that target protein trafficking.

Authors:  P Michael Conn; Timothy P Spicer; Louis Scampavia; Jo Ann Janovick
Journal:  Trends Pharmacol Sci       Date:  2015-06-08       Impact factor: 14.819

Review 6.  Mutations in G protein-coupled receptors that impact receptor trafficking and reproductive function.

Authors:  Alfredo Ulloa-Aguirre; Teresa Zariñán; James A Dias; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2013-06-24       Impact factor: 4.102

Review 7.  Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors.

Authors:  P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Adv Pharmacol       Date:  2011

Review 8.  Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs.

Authors:  P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Trends Endocrinol Metab       Date:  2009-12-11       Impact factor: 12.015

9.  Increased plasma membrane expression of human follicle-stimulating hormone receptor by a small molecule thienopyr(im)idine.

Authors:  Jo Ann Janovick; Guadalupe Maya-Núñez; Alfredo Ulloa-Aguirre; Ilpo T Huhtaniemi; James A Dias; Pieter Verbost; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2008-09-20       Impact factor: 4.102

Review 10.  Enhancement of the surface expression of G protein-coupled receptors.

Authors:  Jill H Dunham; Randy A Hall
Journal:  Trends Biotechnol       Date:  2009-08-11       Impact factor: 19.536

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.